386 related articles for article (PubMed ID: 26996622)
1. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.
Pasqua L; Leggio A; Sisci D; Andò S; Morelli C
Mini Rev Med Chem; 2016; 16(9):743-53. PubMed ID: 26996622
[TBL] [Abstract][Full Text] [Related]
2. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
3. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
4. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of "on-demand" drug release using dual tumor marker mediated DNA-capped versatile mesoporous silica nanoparticles.
Wang S; Liu F; Li XL
Chem Commun (Camb); 2017 Aug; 53(62):8755-8758. PubMed ID: 28726871
[TBL] [Abstract][Full Text] [Related]
6. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
[TBL] [Abstract][Full Text] [Related]
7. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
[TBL] [Abstract][Full Text] [Related]
8. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
9. Targeted Mesoporous Silica Nanocarriers in Oncology.
Baeza A; Vallet-Regi M
Curr Drug Targets; 2018 Feb; 19(3):213-224. PubMed ID: 27262488
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
Dilnawaz F
Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
[TBL] [Abstract][Full Text] [Related]
11. Advances in silica based nanoparticles for targeted cancer therapy.
Yang Y; Yu C
Nanomedicine; 2016 Feb; 12(2):317-32. PubMed ID: 26706409
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.
Lu J; Liong M; Li Z; Zink JI; Tamanoi F
Small; 2010 Aug; 6(16):1794-805. PubMed ID: 20623530
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
15. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J
J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950
[TBL] [Abstract][Full Text] [Related]
16. New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
Sábio RM; Meneguin AB; Ribeiro TC; Silva RR; Chorilli M
Int J Pharm; 2019 Jun; 564():379-409. PubMed ID: 31028801
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
Baeza A; Manzano M; Colilla M; Vallet-Regí M
Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
[TBL] [Abstract][Full Text] [Related]
18. Silica materials in drug delivery applications.
Simovic S; Ghouchi-Eskandar N; Sinn AM; Losic D; Prestidge CA
Curr Drug Discov Technol; 2011 Sep; 8(3):269-76. PubMed ID: 21291408
[TBL] [Abstract][Full Text] [Related]
19. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
Liu J; Liu T; Pan J; Liu S; Lu GQM
Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]